Premium
Industrial Perspective on the Benefits Realized From the FDA’s Model‐Informed Drug Development Paired Meeting Pilot Program
Author(s) -
Galluppi Gerald R.,
Brar Satjit,
Caro Luzelena,
Chen Yuan,
Frey Nicolas,
Grimm Hans Peter,
Rudd Deanne Jackson,
Li ChiChung,
Magee Mindy,
Mukherjee Arnab,
Nagao Lee,
Purohit Vivek S.,
Roy Amit,
Salem Ahmed Hamed,
Sinha Vikram,
Suleiman Ahmed A.,
Taskar Kunal S.,
Upreti Vijay V.,
Weber Benjamin,
Cook Jack
Publication year - 2021
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.2265
Subject(s) - drug development , perspective (graphical) , drug approval , drug , medical physics , medicine , medical education , pharmacology , computer science , artificial intelligence